
Globex Laboratories (R&D) Limited
This company manufactures and trades high-performance pigments and conducts research and development of various chemical products.
This company manufactures and trades high-performance pigments and conducts research and development of various chemical products.
Globex Laboratories (R&D) Limited (GLRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 29 June 1998 and has a history of 26 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Globex Laboratories (R&D) Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.61 Cr.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹31.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harish Goswamy, Neerav Goswamy, and Shakun Goswamy serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
-
U24150MH1998PLC115539
115539
Public Limited Indian Non-Government Company
29 Jun 1998
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shakun Goswamy ![]() | Managing Director | 29-Jun-1998 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harish Goswamy ![]() | Director | 29-Jun-1998 | Current |
Neerav Goswamy ![]() | Director | 29-Jun-1998 | Current |
Globex Laboratories (R&D) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 76.72% increase. The company also saw a substantial improvement in profitability, with a 155.31% increase in profit. The company's net worth Soared by an impressive increase of 17.22%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Globex Laboratories (R&D) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Harish Goswamy, Neerav Goswamy and 1 more are mutual person
₹8.00 Cr
₹31.90 Cr
Date | Lender | Amount | Status |
---|---|---|---|
23 Dec 2020 | Others | ₹8.00 Cr | Open |
24 Dec 2020 | Others | ₹5.00 M | Satisfied |
06 Oct 2015 | Others | ₹9.00 Cr | Satisfied |
18 Apr 2013 | Tata Capital Financial Services Limited | ₹13.00 Cr | Satisfied |
11 Jan 2012 | Others | ₹9.00 Cr | Satisfied |
Globex Laboratories (R&D) has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Globex Laboratories (R&D), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globex Laboratories (R&D)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Globex Laboratories (R&D) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Globex Laboratories (R&D) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge registered on 24 Dec 2020 via Charge ID 100396820 with Others was fully satisfied on 12 Mar 2024.
A charge with Others of Rs. 0.50 Cr registered on 24 Dec 2020 with Charge ID 100396820 was modified on 12 Mar 2021.
A charge with Others of Rs. 8.00 Cr registered on 23 Dec 2020 with Charge ID 100396821 was modified on 12 Mar 2021.
A charge registered on 06 Oct 2015 via Charge ID 10595894 with Others was fully satisfied on 18 Feb 2021.
Globex Laboratories (R&D) Limited was incorporated on 29 Jun 1998.
The authorized share capital of Globex Laboratories (R&D) Limited is ₹ 15.00 Cr and paid-up capital is ₹ 9.61 Cr.
Currently 3 directors are associated with Globex Laboratories (R&D) Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Globex Laboratories (R&D) Limited is 16 Yashodham Shopping Center Film City Road, Goregaon (East) India, Mumbai, Maharashtra, 400063.
The corporate identification number (CIN) of Globex Laboratories (R&D) Limited is U24150MH1998PLC115539 and the company number is 115539 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Globex Laboratories (R&D) Limited has risen by 76.72%.
As Per 2022 financial reports, 29 employees are currently employed by Globex Laboratories (R&D) Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Globex Laboratories (R&D) Limited has experienced an upsurge of 17.22%.
As per the financial statements for fiscal Year 2022, The total open charges for Globex Laboratories (R&D) Limited amount to ₹ 8.00 Cr.
The most recent Balance Sheet for Globex Laboratories (R&D) Limited was filed with the ROC on 31 Mar 2024.
SG
SG